← Back to screener

Innoviva, Inc. INVA

Rank #177 · Nasdaq · $1.6B market cap
Audited by Deloitte & Touche LLP, no going-concern flag in the latest filing.
Score
74.2
P/E
8.7
P/B
2.27
ROE
26.0%
Op. Margin
36.7%
Debt Ratio
88%

Health Check — percentile rank within this universe, based on the latest annual filing

Valuation ★★★★☆
Good

P/E 8.7x, P/B 2.27x. Ranks in the top 23% of the universe.

Profitability ★★★★☆
Excellent

ROE 26.0%. Ranks in the top 11% of the universe.

Safety ★★★☆☆
Good

Debt ratio 88%. Ranks in the top 35% of the universe.

Growth ★☆☆☆☆
Weak

Revenue decline of 6.3% year over year. Ranks in the top 78% of the universe.

Valuation is the relative strength · Growth is the relative weakness (relative to this universe).

Financials annual, from SEC 10-K filings

FYRevenueOp. IncomeNet IncomeEquityOp. Margin%Debt%
2011$0.0B$-0.1B–$-0.1B-333.8-345
2012$0.0B$-0.1B–$-0.2B-323.3-237
2013$0.0B$-0.1B–$-0.0B-447.7-1744
2014$0.0B$-0.0B–$-0.1B-448.0-883
2015$0.0B$-0.0B–$0.2B-635.4236
2016$0.0B$-0.0B–$0.3B-402.337
2017$0.1B$0.0B$-0.0B$-0.4B58.5-207
2018$0.1B$0.1B$0.1B$-0.2B81.6-251
2019$0.2B$0.2B$0.1B$0.2B84.5257
2020$0.3B$0.2B$0.4B$0.3B91.3131
2021$0.3B$0.2B$0.2B$0.5B94.485
2022$0.3B–$0.3B$0.4B–123
2023$0.4B–$0.4B$0.6B–103
2024$0.3B–$0.2B$0.5B–136
2025$0.3B$0.1B$0.2B$0.7B36.788

← See the full screener